TY - JOUR
T1 - Advances in Charcot-Marie-Tooth disease research
T2 - Cellular function of CMT-related proteins, transgenic animal models, and pathomechanisms
AU - Müller, Hans W.
AU - Suter, Ueli
AU - Van Broeckhoven, Christine
AU - Haneman, O.
AU - Nelis, E.
AU - Timmerman, V.
AU - Sancho, S.
AU - Barrio, L.
AU - Bolhuis, P.
AU - Dermietzel, R.
AU - Frank, M.
AU - Gabreëls-Festen, A.
AU - Gillen, C.
AU - Haites, N.
AU - Levi, G.
AU - Mariman, E.
AU - Martini, R.
AU - Nave, K.
AU - Rautenstrauss, B.
AU - Schachner, M.
AU - Schenone, A.
AU - Schneider, C.
AU - Schröder, M.
AU - Willecke, K.
N1 - Funding Information:
This workshop was made possible thanks to the financial support of the European Union BIOMED Concerted Action: ‘‘Clinical, Genetic and Functional Analysis of Peripheral Neuropathies: An Integrated Approach’’ (CT96-1614) and the European Neuromuscular Centre (ENMC). The chairmen H.W. Müller and U. Suter, and the coordinator of the European CMT-Consortium, C. Van Broeckhoven, acknowledge Professor Emery for his scientific advice and M. Rutgers and J. de Vries for excellent organizational support of the workshop.
PY - 1997
Y1 - 1997
N2 - The First Workshop of the European Consortium on Charcot-Marie-Tooth (CMT) disease brought together neuroscientists, molecular and cell biologists, neuropathologists, neurologists, and geneticists with a common interest in the understanding of the fundamental mechanisms that underlie the pathogenesis of CMT. The interdisciplinary group of 25 expert scientists discussed recent advances in (i) molecular genetics and histopathology of CMT, (ii) development of suitable animal models, (iii) understanding of the cellular function of CMT-related proteins, and (iv) studies using nerve biopsies from CMT patients. In this minireview, we summarize the key findings presented and discuss their impact on CMT research.
AB - The First Workshop of the European Consortium on Charcot-Marie-Tooth (CMT) disease brought together neuroscientists, molecular and cell biologists, neuropathologists, neurologists, and geneticists with a common interest in the understanding of the fundamental mechanisms that underlie the pathogenesis of CMT. The interdisciplinary group of 25 expert scientists discussed recent advances in (i) molecular genetics and histopathology of CMT, (ii) development of suitable animal models, (iii) understanding of the cellular function of CMT-related proteins, and (iv) studies using nerve biopsies from CMT patients. In this minireview, we summarize the key findings presented and discuss their impact on CMT research.
UR - http://www.scopus.com/inward/record.url?scp=0030668164&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030668164&partnerID=8YFLogxK
U2 - 10.1006/nbdi.1997.0148
DO - 10.1006/nbdi.1997.0148
M3 - Article
C2 - 9361297
AN - SCOPUS:0030668164
VL - 4
SP - 215
EP - 220
JO - Neurobiology of Disease
JF - Neurobiology of Disease
SN - 0969-9961
IS - 3-4
ER -